A Study to Evaluate the Safety and Effectiveness of the 217z Laser With Zyoptix for Lasik
Sponsor
Bausch & Lomb Incorporated (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT00347997
Collaborator
(none)
0
1
Study Details
Study Description
Brief Summary
A Study to demonstrate the safety and efficacy of wavefront laser refractive surgery treatments for myopia and astigmatism.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
0 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: LASIK LASIK correction of myopia and myopic astigmatism |
Device: 217z Laser
LASIK correction of myopia and myopic astigmatism
|
Outcome Measures
Primary Outcome Measures
- Visual acuity [24 months]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Myopia with or without astigmatism.
Exclusion Criteria:
- Contraindications to LASIK.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Bausch & Lomb Incorporated
Investigators
- Study Director: Mohinder Merchea, OD, PhD, Bausch & Lomb Incorporated
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier:
NCT00347997
Other Study ID Numbers:
- 385
First Posted:
Jul 4, 2006
Last Update Posted:
Dec 8, 2011
Last Verified:
Dec 1, 2011
Additional relevant MeSH terms: